The present study relates subject-paced rapid information processing to different components of event-related brain potentials in an attempt to gain more information about changes in mental performance in relation to alveolar smoke absorption as assessed by expired air CO measurement. The task consisted in the presentation of pseudorandom sequences of single digits, and the subjects had to respond to each sequence of three odd or three even digits. The triplets evoked a typical late negativity in the event-related potential between the second and third digit as well as a P300 component following the third digit. In 21 smokers, task performance, event-related potentials and tidal air CO concentration were measured before and after smoking a cigarette. The results revealed increases in performance and P300 magnitude from pre- to postsmoking which were unaffected by the amount of CO absorption. A differential trend was seen, however, with the late negativity, which increased from pre- to postsmoking only in subjects with a large amount of CO absorption. The results support the assumption of the distraction arousal model used as an interpretation of these effects on contingent negative variation and suggest that high CO absorbing smokers possibly depend more on neuropharmacological effects of smoking than smokers with a low amount of CO absorption.

Keywords:
Event-related potentials, Contingent negative variation, P300, Information processing, Smoking, CO absorption
This content is only available via PDF.
© 1987 S. Karger AG, Basel
1987
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.